P. Wipfli

Plasma Protein Binding of Highly Bound Drugs Determined With Equilibrium Gel Filtration of Nonradiolabeled Compounds and LC-MS/MS Detection.

D. Yuan, J. Isbell, L. Torrão, 2019, Journal of pharmaceutical sciences.

Determination of tezosentan, a parenteral endothelin receptor antagonist, in human plasma by liquid chromatography-tandem mass spectrometry.

J. Dingemanse, P. Wipfli, P. V. van Giersbergen, 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Increasing metabolic stability via the deuterium kinetic isotope effect: An example from a proline-amide-urea aminothiazole series of phosphatidylinositol-3 kinase alpha inhibitors.

C. Schnell, F. Blasco, G. Caravatti, 2016, Bioorganic & medicinal chemistry letters.

A Detailed Investigation on Conformation, Permeability and PK Properties of Two Related Cyclohexapeptides

T. Vorherr, M. Schaefer, T. Wagner, 2015, International Journal of Peptide Research and Therapeutics.

Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945

E. Giorgetti, N. Accart, N. Beckmann, 2018, Acta neuropathologica communications.

Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo.

Daniel R. Beisner, P. Couttet, R. Epple, 2018, Journal of medicinal chemistry.

Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945

Wilfried Frieauff, E. Giorgetti, N. Accart, 2018, Acta Neuropathologica Communications.